9.87
9.87 (0.01%)
As of Nov 22, 2022
Frazier Lifesciences Acquisition Corp [FLAC]
Source:
Company Overview
We are a blank check company incorporated on October7, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this Annual Report on Form 10-K as our initial business combination. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination.
| Country | United States |
| Headquarters | seattle, washington |
| Phone Number | 617-570-8364 |
| Industry | |
| CEO | James N. Topper |
| Website | frazierlifesciencesacquisition.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-0.3 |
| Net Income | $1.4 |
| Net Cash | $-0.4 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | 1% |
| Profit as % of Stockholder Equity | -27.8% |
Management Effectiveness
| Return on Equity | -27.8% |
| Return on Assets | 1% |
| Turnover Ratio | |
| EBITA | $-0.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $139.1 |
| Total Liabilities | $6 |
| Operating Cash Flow | $-0.4 |
| Investing Cash Flow | |
| Financing Cash Flow | $-0 |
